Abstract
COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected millions of people around the globe. We study the spread of SARS-CoV-2 across six rural counties in North and South Dakota in the United States. The study period is from early March 2020 to mid-June 2021, from near the onset of the pandemic to just before the arrival of the Delta variant in the United States. We model the transmission dynamics in each county using a stochastic compartmental model and analyse the data within a Bayesian hierarchical statistical framework. We estimate the model parameters and characterise the effects of non-pharmaceutical interventions (NPIs) implemented at the time. Counterfactual analyses in which NPIs were lifted earlier indicate that notified cases may have increased by up to 51% in the case of low NPI stringency levels with potential additional deaths. Our study underscores the importance of timely public health measures and compliance with them. From a methodological perspective, our study demonstrates that despite the inherent high variability in epidemic behaviour in small rural communities, the combination of stochastic modelling and application of Bayesian hierarchical analyses can support the quantitative evaluation of the impact of public health measures in small low population density communities.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Punya Alahakoon was supported by a PhD Research Scholarship from the University of Melbourne. P.G. Taylor would like to acknowledge the support of the Australian Research Council via the Centre of Excellence for Mathematical and Statistical Frontiers (ACEMS).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All the data used in this study are publicly available on https://github.com/covid19datahub. All the codes and relevant details are available at https://github.com/PunyaAlahakoon/COVID_19_in_US_rural_counties.git
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All the codes, data and relevant details are available at https://github.com/PunyaAlahakoon/COVID_19_in_US_rural_counties.git
https://github.com/PunyaAlahakoon/COVID_19_in_US_rural_counties.git
